Ozanimod Lessens Inflammation in Crohn’s, Early Phase 2 Trial Data Show
News
Daily treatment with 1 mg of ozanimod reduced gut inflammation in patients with moderately to severely active Crohn’s disease, early data from the phase 2 STEPSTONE study show. B.G. Feagan ... Read more